Analgesics Market Research Report by Type (Non-opioids and Opioids), by Route of Administration (Intravenous, Oral, Rectal, Topical, and Transdermal) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Analgesics Market is expected to grow from USD 17,123.67 Million in 2020 to USD 24,885.92 Million by the end of 2025.
2. The Global Analgesics Market is expected to grow from EUR 15,014.35 Million in 2020 to EUR 21,820.44 Million by the end of 2025.
3. The Global Analgesics Market is expected to grow from GBP 13,347.79 Million in 2020 to GBP 19,398.42 Million by the end of 2025.
4. The Global Analgesics Market is expected to grow from JPY 1,827,529.50 Million in 2020 to JPY 2,655,958.27 Million by the end of 2025.
5. The Global Analgesics Market is expected to grow from AUD 24,865.84 Million in 2020 to AUD 36,137.66 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Analgesics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Analgesics Market studied across Non-opioids and Opioids.
Based on Route of Administration, the Analgesics Market studied across Intravenous, Oral, Rectal, Topical, and Transdermal.
Based on Geography, the Analgesics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Analgesics Market including Abbott Laboratories, AbbVie Inc., Aspen Pharmacare Holdings Limited, Astrazeneca PLC, B. Braun Melsungen AG, Baxter International Inc., Boehringer Ingelheim International GmbH, Braun Melsungen AG, Claris Life sciences, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Hospira, Inc, Maruishi Pharmaceutical Co., Ltd., Mylan NV, Pacira Pharmaceuticals, Inc., Paion UK Ltd, Pfizer Inc., Piramal Enterprises LTD, Septodont, Teva Pharmaceutical Industries Limited, and Troikaa Pharmaceuticals Ltd.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Analgesics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Analgesics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Analgesics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Analgesics Market?
4. What is the competitive strategic window for opportunities in the Global Analgesics Market?
5. What are the technology trends and regulatory frameworks in the Global Analgesics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Analgesics Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Analgesics Market is expected to grow from USD 17,123.67 Million in 2020 to USD 24,885.92 Million by the end of 2025.
2. The Global Analgesics Market is expected to grow from EUR 15,014.35 Million in 2020 to EUR 21,820.44 Million by the end of 2025.
3. The Global Analgesics Market is expected to grow from GBP 13,347.79 Million in 2020 to GBP 19,398.42 Million by the end of 2025.
4. The Global Analgesics Market is expected to grow from JPY 1,827,529.50 Million in 2020 to JPY 2,655,958.27 Million by the end of 2025.
5. The Global Analgesics Market is expected to grow from AUD 24,865.84 Million in 2020 to AUD 36,137.66 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Analgesics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Analgesics Market studied across Non-opioids and Opioids.
Based on Route of Administration, the Analgesics Market studied across Intravenous, Oral, Rectal, Topical, and Transdermal.
Based on Geography, the Analgesics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Analgesics Market including Abbott Laboratories, AbbVie Inc., Aspen Pharmacare Holdings Limited, Astrazeneca PLC, B. Braun Melsungen AG, Baxter International Inc., Boehringer Ingelheim International GmbH, Braun Melsungen AG, Claris Life sciences, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Hospira, Inc, Maruishi Pharmaceutical Co., Ltd., Mylan NV, Pacira Pharmaceuticals, Inc., Paion UK Ltd, Pfizer Inc., Piramal Enterprises LTD, Septodont, Teva Pharmaceutical Industries Limited, and Troikaa Pharmaceuticals Ltd.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Analgesics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Analgesics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Analgesics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Analgesics Market?
4. What is the competitive strategic window for opportunities in the Global Analgesics Market?
5. What are the technology trends and regulatory frameworks in the Global Analgesics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Analgesics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Route of Administration Outlook
3.4. Type Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
5.1.1.2. Frequent pain and aches encountered by the aging population
5.1.1.3. Cost-efficiency of OTC analgesics drugs
5.1.2. Restraints
5.1.2.1. Uncontrolled prescriptions of opioids and drug abuse
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D by the public & private sectors
5.1.3.2. Surge in popularity of personalized medicine
5.1.4. Challenges
5.1.4.1. Limited availability and affordability of high efficacy drugs, including opioid analgesics
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANALGESICS MARKET, BY TYPE
6.1. Introduction
6.2. Non-opioids
6.3. Opioids
7. GLOBAL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
7.1. Introduction
7.2. Intravenous
7.3. Oral
7.4. Rectal
7.5. Topical
7.6. Transdermal
8. AMERICAS ANALGESICS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC ANALGESICS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. AbbVie Inc.
12.3. Aspen Pharmacare Holdings Limited
12.4. Astrazeneca PLC
12.5. B. Braun Melsungen AG
12.6. Baxter International Inc.
12.7. Boehringer Ingelheim International GmbH
12.8. Braun Melsungen AG
12.9. Claris Life sciences
12.10. Eisai Co. Ltd.
12.11. F. Hoffmann-La Roche Ltd
12.12. Fresenius SE & Co. KGaA
12.13. Glenmark Pharmaceuticals Limited
12.14. Hikma Pharmaceuticals PLC
12.15. Hospira, Inc
12.16. Maruishi Pharmaceutical Co., Ltd.
12.17. Mylan NV
12.18. Pacira Pharmaceuticals, Inc.
12.19. Paion UK Ltd
12.20. Pfizer Inc.
12.21. Piramal Enterprises LTD
12.22. Septodont
12.23. Teva Pharmaceutical Industries Limited
12.24. Troikaa Pharmaceuticals Ltd
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Route of Administration Outlook
3.4. Type Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
5.1.1.2. Frequent pain and aches encountered by the aging population
5.1.1.3. Cost-efficiency of OTC analgesics drugs
5.1.2. Restraints
5.1.2.1. Uncontrolled prescriptions of opioids and drug abuse
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D by the public & private sectors
5.1.3.2. Surge in popularity of personalized medicine
5.1.4. Challenges
5.1.4.1. Limited availability and affordability of high efficacy drugs, including opioid analgesics
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANALGESICS MARKET, BY TYPE
6.1. Introduction
6.2. Non-opioids
6.3. Opioids
7. GLOBAL ANALGESICS MARKET, BY ROUTE OF ADMINISTRATION
7.1. Introduction
7.2. Intravenous
7.3. Oral
7.4. Rectal
7.5. Topical
7.6. Transdermal
8. AMERICAS ANALGESICS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC ANALGESICS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. AbbVie Inc.
12.3. Aspen Pharmacare Holdings Limited
12.4. Astrazeneca PLC
12.5. B. Braun Melsungen AG
12.6. Baxter International Inc.
12.7. Boehringer Ingelheim International GmbH
12.8. Braun Melsungen AG
12.9. Claris Life sciences
12.10. Eisai Co. Ltd.
12.11. F. Hoffmann-La Roche Ltd
12.12. Fresenius SE & Co. KGaA
12.13. Glenmark Pharmaceuticals Limited
12.14. Hikma Pharmaceuticals PLC
12.15. Hospira, Inc
12.16. Maruishi Pharmaceutical Co., Ltd.
12.17. Mylan NV
12.18. Pacira Pharmaceuticals, Inc.
12.19. Paion UK Ltd
12.20. Pfizer Inc.
12.21. Piramal Enterprises LTD
12.22. Septodont
12.23. Teva Pharmaceutical Industries Limited
12.24. Troikaa Pharmaceuticals Ltd
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANALGESICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. AMERICAS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ARGENTINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ARGENTINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. BRAZIL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. BRAZIL ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. CANADA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. CANADA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MEXICO ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MEXICO ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. UNITED STATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. UNITED STATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. AUSTRALIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AUSTRALIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CHINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CHINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. INDONESIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. INDONESIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. JAPAN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. JAPAN ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MALAYSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. MALAYSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. PHILIPPINES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. PHILIPPINES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. SOUTH KOREA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. SOUTH KOREA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. THAILAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. THAILAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. FRANCE ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. FRANCE ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. GERMANY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. GERMANY ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ITALY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ITALY ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. NETHERLANDS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. NETHERLANDS ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. QATAR ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. QATAR ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. RUSSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. RUSSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SAUDI ARABIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SAUDI ARABIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SPAIN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SPAIN ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED KINGDOM ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. UNITED KINGDOM ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. GLOBAL ANALGESICS MARKET: SCORES
TABLE 73. GLOBAL ANALGESICS MARKET: BUSINESS STRATEGY
TABLE 74. GLOBAL ANALGESICS MARKET: PRODUCT SATISFACTION
TABLE 75. GLOBAL ANALGESICS MARKET: RANKING
TABLE 76. GLOBAL ANALGESICS MARKET: MERGER & ACQUISITION
TABLE 77. GLOBAL ANALGESICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 78. GLOBAL ANALGESICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 79. GLOBAL ANALGESICS MARKET: INVESTMENT & FUNDING
TABLE 80. GLOBAL ANALGESICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 81. GLOBAL ANALGESICS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANALGESICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. AMERICAS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ARGENTINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ARGENTINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. BRAZIL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. BRAZIL ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. CANADA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. CANADA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MEXICO ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MEXICO ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. UNITED STATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. UNITED STATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. AUSTRALIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AUSTRALIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CHINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CHINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. INDONESIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. INDONESIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. JAPAN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. JAPAN ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MALAYSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. MALAYSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. PHILIPPINES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. PHILIPPINES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. SOUTH KOREA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. SOUTH KOREA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. THAILAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. THAILAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. FRANCE ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. FRANCE ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. GERMANY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. GERMANY ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ITALY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ITALY ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. NETHERLANDS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. NETHERLANDS ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. QATAR ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. QATAR ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. RUSSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. RUSSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SAUDI ARABIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SAUDI ARABIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SPAIN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SPAIN ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED KINGDOM ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. UNITED KINGDOM ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. GLOBAL ANALGESICS MARKET: SCORES
TABLE 73. GLOBAL ANALGESICS MARKET: BUSINESS STRATEGY
TABLE 74. GLOBAL ANALGESICS MARKET: PRODUCT SATISFACTION
TABLE 75. GLOBAL ANALGESICS MARKET: RANKING
TABLE 76. GLOBAL ANALGESICS MARKET: MERGER & ACQUISITION
TABLE 77. GLOBAL ANALGESICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 78. GLOBAL ANALGESICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 79. GLOBAL ANALGESICS MARKET: INVESTMENT & FUNDING
TABLE 80. GLOBAL ANALGESICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 81. GLOBAL ANALGESICS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ANALGESICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANALGESICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANALGESICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANALGESICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL ANALGESICS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL ANALGESICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2025
FIGURE 16. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 19. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 21. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, 2020 VS 2025 (USD MILLION)
FIGURE 26. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 27. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 29. ARGENTINA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. BRAZIL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. CANADA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. MEXICO ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. UNITED STATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 35. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 37. AUSTRALIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. CHINA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. INDIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. INDONESIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. JAPAN ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. MALAYSIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. PHILIPPINES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. SOUTH KOREA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. THAILAND ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. FRANCE ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. GERMANY ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. ITALY ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. NETHERLANDS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. QATAR ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. RUSSIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SAUDI ARABIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SOUTH AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SPAIN ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED KINGDOM ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. GLOBAL ANALGESICS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
FIGURE 61. GLOBAL ANALGESICS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
FIGURE 62. GLOBAL ANALGESICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANALGESICS MARKET, BY TYPE
FIGURE 1. GLOBAL ANALGESICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANALGESICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANALGESICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANALGESICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL ANALGESICS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL ANALGESICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2025
FIGURE 16. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 19. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 21. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, 2020 VS 2025 (USD MILLION)
FIGURE 26. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 27. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 29. ARGENTINA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. BRAZIL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. CANADA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. MEXICO ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. UNITED STATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 35. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 37. AUSTRALIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. CHINA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. INDIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. INDONESIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. JAPAN ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. MALAYSIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. PHILIPPINES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. SOUTH KOREA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. THAILAND ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. FRANCE ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. GERMANY ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. ITALY ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. NETHERLANDS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. QATAR ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. RUSSIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SAUDI ARABIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SOUTH AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SPAIN ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED KINGDOM ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. GLOBAL ANALGESICS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
FIGURE 61. GLOBAL ANALGESICS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
FIGURE 62. GLOBAL ANALGESICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANALGESICS MARKET, BY TYPE
